VALIDITY OF PATIENT REPORTED OUTCOME MEASUREMENT INFORMATION SYSTEM HEALTH ASSESSMENT QUESTIONNAIRE (PROMIS HAQ) FOR ASSESSING DISEASE ACTIVITY IN IRAQI PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

Abstract

Objective: Rheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory disease that affects all ethnic groups throughout the world. Biochemical and clinical data are required to evaluate the disease activity and responsiveness to treatment. Disease activity score of 28 joints (DAS28) and simplified disease activity index (SDAI) are common tools that used to assess disease activity, whereas the Patient Reported Outcome Measurement Information System health assessment questionnaire (PROMIS HAQ) and HAQDI is a useful tool to assess the extent of the patient’s functional ability. This study aimed to evaluate the effectiveness of PROMIS HAQ score for monitoring disease activity and response to therapy in Iraqi patients with active rheumatoid arthritis.Methods: A cross-sectional study was conducted in Baghdad Teaching Hospital, Rheumatology outpatient Unit from September 2012 to April. A total of 140 patients (40 males and 100 females) with active RA were involved in this study Disease activity was measured by DAS28 and the SDAI whereas functional status of the patients was measured using PROMIS HAQ score.Results: There was a significant positive correlation of PROMIS HAQ score with clinical parameters like swelling joint count (SJC), tender joint count (TJC), visual analogue scale (VAS) and physician global assessment (EGA). Additionally PROMIS HAQ was significantly correlated with simplified disease activity index (SDAI). Furthermore it correlated with inflammatory marker CRP. Conclusion: PROMIS HAQ score is a valid and useful tool to monitor disease activity and response to treatment in Iraqi patients with highly active RA.Conclusion: PROMIS HAQ score is a valid and useful tool to monitor disease activity and response to treatment in Iraqi patients with highly active RA. 

Authors and Affiliations

Samer Imad Mohammed

Keywords

Related Articles

PREPARATION AND EVALUATION OF RAPIDLY DISSOLVING TABLETS OF RALOXIFENE HYDROCHLORIDE BY TERNARY SYSTEM FORMATION

Objectives: Enhancing the dissolution rate of raloxifene hydrochloride for the preparation of rapidly disintegrating tablets with subsequent rapid dissolution.Methods: Binary and ternary solid dispersions (SDs) with diff...

REVIEW ON ANTIHYPERLIPEDEMIA LIPOPHILIC DRUGS AND THEIR NOVEL FORMULATION APPROACHES

It has been ranked as one of the greatest risk factors contributing to prevalence and severity of coronary heart diseases (CHD). CHD, stroke, atherosclerosis and hyperlipidemia are the primary cause of death. The increas...

IMPACT OF PROLONGED REDUCED-PRESSURE CONDITION PRIOR TO PRECURSOR LABELING ON THE LABELING EFFICIENCY OF F-18 FLUOROCHOLINE SYNTHESIS

Objective: The goal of this preliminary work was to observe the impact of the prolonged reduced-pressure condition prior to labeling stage on the F-18 Fluorocholine labeling yield at the end of synthesis.Methods: At this...

FORMULATION, OPTIMIZATION AND IN VITRO EVALUATION OF GASTRORETENTIVE MUCOADHESIVE MICROSPHERES OF FUROSEMIDE

Objective: The objective of this study was to formulate and evaluate sustained release gastro retentive microspheres of furosemide using mucoadhesive polymers. It was expected that gastro retention plus mucoadhesion woul...

EVALUATION OF PHYTOCONSTITUENTS, IN VITRO ANTIOXIDANT AND ANTIMICROBIAL ACTIVITIES OF AGARICUS BISPORUS

Objective: The present study was aimed to investigate the phytochemicals, antimicrobial and antioxidant potential of wild edible mushroom (Agaricus bisporus). Methods: Initially, phytochemical screening was carried out t...

Download PDF file
  • EP ID EP579719
  • DOI -
  • Views 54
  • Downloads 0

How To Cite

Samer Imad Mohammed (2014). VALIDITY OF PATIENT REPORTED OUTCOME MEASUREMENT INFORMATION SYSTEM HEALTH ASSESSMENT QUESTIONNAIRE (PROMIS HAQ) FOR ASSESSING DISEASE ACTIVITY IN IRAQI PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. International Journal of Pharmacy and Pharmaceutical Sciences, 6(8), 332-334. https://europub.co.uk/articles/-A-579719